Acquisition enables Astellas to fully utilize proprietary technology to produce pluripotent stem cells that have the potential to lower immunological rejection in numerous therapeutic areas

- A total of 10 abstracts and one trial in progress (TIP) across various cancers to be presented during oral and poster sessions -

- Gilteritinib combined with intensive chemotherapy was well-tolerated in newly diagnosed AML patients -

- Accelerating the Discovery and Development of Novel Drugs that Target Mitochondrial Functions -

- A breadth of abstracts highlighting the acute myeloid leukemia treatment landscape, healthcare resource use and cost of care to be presented during oral and poster sessions -

- Grand Prize winner Hernâni Oliveira of Porto, Portugal will receive a $50,000 grant from Astellas plus a one-year nights and weekends membership to MATTER, a healthcare innovation community -

ADC Combination Study Focuses on First-Line Treatment

James Miteff and Gregory Apostol promoted to key national leadership roles.

In the challenge's second year, five entrants will compete for a chance to win a Grand Prize of $50,000 from Astellas and a consultation with Robert Herjavec, star of ABC's Emmy Award-winning hit television show, Shark Tank